Literature DB >> 21132548

Dermatomyositis with anti-OJ antibody.

Shinji Noda, Yoshihide Asano, Zenshiro Tamaki, Megumi Hirabayashi, Mizuho Yamamoto, Tomonori Takekoshi, Toshihiko Hoashi, Makoto Sugaya, Rieko Morimoto, Takafumi Etoh, Kenzo Kaji, Manabu Fujimoto, Masataka Kuwana, Shinichi Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21132548     DOI： 10.1007/s00296-010-1695-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  4 in total

1.  Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.

Authors:  S Sato; M Kuwana; M Hirakata
Journal:  Rheumatology (Oxford)       Date:  2007-01-25       Impact factor: 7.580

2.  Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.

Authors:  I N Targoff; E P Trieu; F W Miller
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 3.  Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.

Authors:  Tsuneyo Mimori; Yoshitaka Imura; Ran Nakashima; Hajime Yoshifuji
Journal:  Curr Opin Rheumatol       Date:  2007-11       Impact factor: 5.006

Review 4.  Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.

Authors:  Harsha Gunawardena; Zoe E Betteridge; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580
  4 in total
  1 in total

1.  PLCε1 regulates SDF-1α-induced lymphocyte adhesion and migration to sites of inflammation.

Authors:  Marianne Strazza; Inbar Azoulay-Alfaguter; Michael Peled; Alan V Smrcka; Edward Y Skolnik; Shekhar Srivastava; Adam Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-17       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.